Euromedis Sp. z o.o.

At Euromedis Sp. z o.o. in Szczecin, much of the research focuses on nervous system diseases, especially Alzheimer’s disease, multiple sclerosis, migraine, Parkinson’s disease, and related conditions. These studies are designed to assess new treatment options, track disease progression, and better understand long-term safety and effectiveness.

• Research in Alzheimer’s disease and other neurocognitive disorders aims to improve care for people in the early and progressive stages of illness.
• Trials in multiple sclerosis explore ways to reduce relapses and slow disability progression.
• Migraine studies evaluate preventive therapies for both adults and children.
• Work in Parkinson’s disease looks at symptoms such as apathy and quality of life.

Overall, the site is active in testing therapies that may help people living with chronic and often progressive brain and nerve disorders.

The site also supports clinical research in mental disorders, with a particular interest in schizophrenia and cognitive symptoms linked to psychiatric illness. These trials focus on finding better ways to manage thinking difficulties and improve everyday functioning.

• Schizophrenia studies examine whether new approaches can support cognition and long-term stability.
• Research on mental disorders includes follow-up evaluations to better understand treatment benefit and safety over time.
• Some studies look at symptom relief in people who continue to experience cognitive impairment after prior treatment.

This area of research reflects a broader effort to improve both psychiatric care and the quality of life of affected patients.

Clinical trials at Euromedis Sp. z o.o. include work in immune system diseases, particularly multiple sclerosis and its progressive or relapsing forms. The research is centered on evaluating therapies that may better control immune-driven damage in the central nervous system.

• Relapsing multiple sclerosis and primary progressive multiple sclerosis are key conditions under study.
• Trials aim to determine whether new or improved treatments can reduce relapses and slow worsening disability.
• Some studies also examine imaging and biomarker changes to understand treatment impact more clearly.

These investigations are important for advancing care in chronic autoimmune conditions with long-term neurological effects.

Research in this therapeutic area includes urinary incontinence, with studies focused on female participants living with stress-related symptoms. The main goal is to assess whether new treatment approaches can reduce leakage episodes and improve daily comfort.

• Urinary incontinence trials address a common condition that can affect physical activity and wellbeing.
• These studies are designed to evaluate symptom improvement and treatment tolerability.
• The research supports better options for women seeking non-surgical management of bladder control problems.

This area adds an important women’s health dimension to the site’s broader clinical trial portfolio.